Eileen Smith, MD, Medical Director of City of Hope’s Alpha Stem Cell Clinic, Associate Director of the Clinical Research Program, Clinical Professor in the Department of Hematology & Hematopoietic Cell Transplantation, has been appointed the new Chair of the Department of Hematology & Hematopoietic Cell Transplantation.
Eileen Smith, MD
Stephen J. Forman, MD
Stephen J. Forman, MD, who served in this role for more than 30 years, has decided to transition out of the role of Chair but will continue in his roles as Director of the Hematologic Malignancies Research Institute and Director of the T-Cell Therapeutics Research Laboratory. Dr. Forman, an expert in leukemia, lymphoma, bone marrow transplantation, and chimeric antigen receptor T cell, has been working to advance survival rates for blood cancers. Under his leadership, the program completed its 15,000th bone marrow transplant this past year, now performing nearly 800 transplants annually.
Professional Experience and Education
A specialist in the field of hematology and cell transplantation, Dr. Smith joined City of Hope nearly three decades ago as the inaugural fellow in bone marrow transplantation. She later joined the Hematopoietic Stem Cell Transplant Team at the University of Wisconsin Hospital & Clinics, where she served as Director of the program. Dr. Smith returned to City of Hope in 2003 as Associate Director of the Clinical Research Program. In 2010, she became Clinical Professor in the Department of Hematology & Hematopoietic Cell Transplantation, and in 2011, an associate member of the Hematologic Malignancies Program.
As a clinician, educator, and administrative leader, her research interest is in Hodgkin lymphoma. Dr. Smith is a physician co-leader of the multidisciplinary Theranostics Modality Team at City of Hope, initiated in August 2016, and has been charged with promoting, reviewing, and prioritizing research proposals of novel radiopharmaceuticals for imaging protocols and radioimmunotherapy-based interventional trials for patients with cancer.
In her new role as Chair of the department, Dr. Smith will provide oversight of all clinical treatments to improve outcomes for patients with leukemia, lymphoma, myeloma, myelodysplastic syndromes, and any other hematologic condition.
Dr. Smith received her medical degree from the University of Southern California School of Medicine, where she also did a fellowship in hematology.
